The impact of COVID-19 on people receiving Opioid Agonist Treatment (OAT)
OnlineThis presentation will draw on the experiences of people receiving and providing Opioid Agonist Treatment (OAT) during COVID-19. The COVID-19 pandemic required Opioid Agonist Treatment (OAT) services to adapt quickly to ensure continuity of care. The CHOICE Study uses data collected from 70 in-depth interviews (40 people receiving OAT; 30 providers) to explore how OAT […]